Syntax Advisors’s Eli Lilly LLY Stock Holding History

Syntax Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$213K	Sell	396 -119	-23%	-$61.3K	0.19%	164
2023 Q2	$242K	Sell	515 -247	-32%	-$104K	0.19%	140
2023 Q1	$262K	Buy	762 +91	+14%	+$30.7K	0.2%	127
2022 Q4	$245K	Sell	671 -141	-17%	-$50K	0.2%	135
2022 Q3	$263K	Buy	812 +6	+0.7%	+$1.9K	0.22%	95
2022 Q2	$261K	Sell	806 -57	-7%	-$17.1K	0.22%	102
2022 Q1	$247K	Sell	863 -201	-19%	-$51.7K	0.21%	145
2021 Q4	$294K	Buy	+1,064	New	+$270K	0.22%	94

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Syntax Advisors's LLY Position: Q3 2023 in Review

Syntax Advisors reduced its Eli Lilly (LLY) stake by 23% in Q3 2023, selling an estimated $61.3K and leaving 396 shares worth $213K. The position accounts for 0.19% of the portfolio, ranked #164.

Syntax Advisors first reported a position in LLY in Q4 2021 and has held it in 8 quarters since. The position peaked at $294K in Q4 2021. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

Syntax Advisors held 396 shares of Eli Lilly worth $213K as of Q3 2023.
Syntax Advisors sold 119 Eli Lilly shares in Q3 2023, an estimated $61.3K.
Eli Lilly made up 0.19% of Syntax Advisors's portfolio in Q3 2023, its #164 holding.
Syntax Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 8 quarters since.
Syntax Advisors's Eli Lilly position peaked at $294K in Q4 2021.
2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.